Lytix Biopharma AS (OSL:LYTIX)
Norway
· Delayed Price · Currency is NOK 8.60
-0.08 (-0.92%)
Jun 6, 2025, 4:25 PM CET
Lytix Biopharma AS Market Cap
Lytix Biopharma AS has a market cap or net worth of 587.05 million as of June 6, 2025. Its market cap has increased by 123.27% in one year.
Market Cap
587.05M
Enterprise Value
472.03M
Revenue
608.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
8.60
Market Cap Chart
Since June 14, 2021, Lytix Biopharma AS's market cap has decreased from 720.55M to 587.05M, a decrease of -18.53%. That is a compound annual growth rate of -5.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 6, 2025 | 587.05M | 46.26% |
| Dec 30, 2024 | 401.38M | 106.12% |
| Dec 29, 2023 | 194.73M | -37.37% |
| Dec 30, 2022 | 310.93M | -41.63% |
| Dec 30, 2021 | 532.66M | -26.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 3.78B |
| Nordhealth AS | 3.19B |
| Photocure ASA | 1.37B |
| Vistin Pharma ASA | 1.07B |
| Omda AS | 1.04B |
| Gentian Diagnostics ASA | 943.85M |
| ArcticZymes Technologies ASA | 819.70M |
| Thor Medical ASA | 800.17M |